Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages
- 1 September 1990
- Vol. 71 (3) , 215-217
- https://doi.org/10.1016/0041-3879(90)90079-n
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige miceAntimicrobial Agents and Chemotherapy, 1988
- In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige miceAntimicrobial Agents and Chemotherapy, 1988
- Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditionsAntimicrobial Agents and Chemotherapy, 1988
- Intracellular Killing of Mycobacterium avium Complex by Rifapentine and Liposome-Encapsulated AmikacinThe Journal of Infectious Diseases, 1987
- Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome deliveryAntimicrobial Agents and Chemotherapy, 1983
- Enhanced intracellular killing ofStaphylococcus aureus by canine monocytes treated with liposomes containing amikacin, gentamicin, kanamycin, and tobramycinCurrent Microbiology, 1981
- Killing of Intraphagocytic Staphylococcus aureus by Dihydrostreptomycin Entrapped Within LiposomesAntimicrobial Agents and Chemotherapy, 1978